Neudle.com: multiple sclerosis familial

Differential
(Click to cross reference)

abdominal cramps

abdominal reflex, absent

acute disseminated encephalomyelitis

Addison's disease

adrenoleukodystrophy

adrenoleukodystrophy, adult onset

adrenoleukodystrophy, carrier

Alexanders disease, adult onset

aminoacidopathies

aminoacidurias

amnestic syndrome

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, prognosis

anatomy of

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

attention deficit disorder with hyperactivity

autonomic dysfunction

Babinski sign

baclofen

basal ganglia, infarction

basal ganglia, lesion of

behavioral disorder

benign essential tremor

beta adrenergic blocker

bladder dysfunction

blink reflex

bone marrow transplantation

brain biopsy

brainstem

brainstem, infarction of

brainstem, lesion of

burning paresthesia

calcification, intracranial

Canavan's disease

CAT scan

CAT scan, abnormal

CAT scan, demyelinating disease

CAT scan, serial

catecholamine

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebral venous infarction

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, immunoglobulins of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrovascular accident

cerebrovascular accident, familial occurrence

cerebrovascular accident, infancy and childhood

cerebrovascular accident, multiple

cerebrovascular accident, nonvascular territory

cerebrovascular accident, recurrent

cerebrovascular accident, young adult

cerebrovascular disease, cardiovascular disease with

Charcot-Marie-Tooth

children

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

cognition

congenital malformation

congestive heart failure

corneal dystrophy

cortical blindness

cortical blindness, transient

degenerative diseases of CNS

dementia

dementia, cerebrovascular disease causing

dementia, presenile

dementia, subcortical

dementia, thalamic

demyelinating disease

dentate nuclei

dentate nuclei, lesion of

differential diagnosis

dilantin

diplopia

disability, neurological

dopamine

drug induced neurologic disorders

dysarthria

dysarthria-clumsy hand syndrome

dysdiadochokinesia

dysphagia

dystonia

dystonia musculorum deformens

echocardiogram

echolalia

electrical sensation

electrocardiogram, abnormal

electroencephalogram, abnormalities of

encephalopathy, metabolic

facial weakness, bilateral

gamma amino butyric acid

gamma amino butyric acid-mimetic drug

genetic diagnosis, prenatal

genetic linkage

genetic neurologic disorders

genetic screening

genetic testing

Gilles de la Tourette syndrome

glioma

glutaric acidemia

granular osmiphilic material

hearing loss, bilateral

heavy metal intoxication

hemianopia

hemianopia, transient

hemiparesis

hemiparesis, transient

hemiplegia

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

human immunodeficiency virus type 1

human T-lymphotropic virus type I(HTLV-I)

hypoxic encephalopathy

iatrogenic neurologic disorders

imbalance

incoordination

intellectual deficit

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intrathecal antispasticity drugs

Leber's hereditary optic neuropathy

Leigh's disease

Leigh's disease, adult variety

leukodystrophy

leukoencephalopathy

leukoencephalopathy, differential diagnosis

level of consciousness, decreased

Lhermitte's sign

lipid storage disorder of CNS

liver disease

Lorenzo's oil

low birth weight

magnetic susceptibility

malformation, CNS, congenital

maple syrup urine disease

MELAS syndrome

mental retardation

metabolic disorder, primary

metachromatic leukodystrophy

metronidazole

microhemorrhage, intracerebral

migraine

misdiagnosis

mitochondrial disease

MRI, CAT scan compared to

MRI, complications with

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, negative

MRI, paramagnetic effect

MRI, serial

MRI, spinal cord

MRI, T1 weighted high signal foci

MRI, volumetry

multiple sclerosis

multiple sclerosis, asymptomatic

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conjugal

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, linoleic acid in

multiple sclerosis, misdiagnosis

multiple sclerosis, parental transmission

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, risk factors for

multiple sclerosis, spinal form

multiple sclerosis, treatment of

muscle biopsy

myelin basic protein gene

myelinolysis, extrapontine

myelitis

myelitis, longitudinal

myelitis, transverse

myelomalacia

myelopathy

myelopathy, chronic progressive

myocardial infarction

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuropathology

neuropathy

neuropathy, peripheral

obsessive-compulsive disorder

occipital lobe, infarction

occipital lobe, lesion of

old age, neurology of

optic atrophy

optic atrophy, bilateral

optic atrophy, hereditary

optic nerve, hypoplasia of

optic neuritis

optic neuritis, bilateral

optic neuropathy

optic neuropathy, bilateral

optic neuropathy, hereditary

paraparesis, spastic, tropical

paraplegia

paratrigeminal syndrome

paresthesias

Parkinson disease

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

PAS positive

PAS positive material in the brain

Pelizaeus Merzbacher

periventricular leukomalacia

phenylketonuria

phenylketonuria, adult onset

pimozide

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

polymerase chain reaction

pons, lesion of

posterior cerebral artery territory infarction

posterior leukoencephalopathy syndrome

premature infant

prevention of neurologic disorders

primary lateral sclerosis

psychiatric problems in neurologic disorders

pyramidal tract dysfunction

quadriparesis

quadriplegia

quality of life

radiation therapy, stereotactic

reversible neurologic disorder

sensorineural hearing loss

sick sinus syndrome

skin, biopsy

skin, lesions in neurologic disorders

smell

spasticity

spasticity, treatment of

speech disorder

speech, loss of

spinal cord

spinal cord, injury of

spinal cord, injury, management of

spinal cord, lesion of

spontaneous remission

steroid therapy, CNS treatment and complications with

stimulation, deep brain

symmetric brain lesions

systemic lupus erythematosus

tardive dyskinesia

taste

Tay-Sachs disease

temporal lobe, lesion, bilateral

thalamic tumors

thalamic tumors, bilateral

thalamotomy

thalamus

thalamus, infarction of

thalamus, infarction, bilateral

thalamus, lesion of

thalamus, lesion of-bilateral

tongue, impaired movements of

top of the basilar syndrome

torticollis

transient ischemic attack

transient ischemic attack, recurrent

transient neurologic deficit

trauma

treatment of neurologic disorder

tremor

tremor, cerebellar

tremor, classification

tremor, differential diagnosis of

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

very long chain fatty acids

viral infection

viral infection, CNS

vision loss, sequential

visual acuity, decreased

visual evoked response

visual loss

visual loss, progressive

visual loss, sudden

visual loss, transient

walking, difficulty with

water channel antibodies

weakness

Wernicke's encephalopathy

white matter disease

workup

Showing articles 600 to 650 of 5493 << Previous Next >>

Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007

NMO-IgG in the Diagnosis of Neuromyelitis Optica
Neurol 68:1076-1077, Jarius,S.,et al, 2007

Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Neurologic Complications of Gastric Bypass Surgery for Morbid Obesity
Neurol 68:1843-1850, Juhasz-Pocsine,K.,et al, 2007

Orthostatic Myoclonus: A Contributor to Gait Decline in Selected Elderly
Neurol 68:1826-1830, Glass,G.A.,et al, 2007

Mitoxantrone for Multiple Sclerosis Causing Acute Lymphoblastic Leukemia
Neurol 68:1630-1631, Cartwright,M.S.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Balos Concentric Sclerosis Presenting as a Stroke-Like Syndrome
Nat Clin Pract Neurol 3:349-354, Mowry,E.M.,et al, 2007

The Differential Diagnosis of Multiple Sclerosis
Neurologist 13:57-72, Rolak, L.A.,et al, 2007

Clinical Spectrum of Mutations in SCN1A Gene: Severe Myoclonic Epilepsy in Infancy and Related Epilepsies
Epilepsy Res 70S:S223-S230, Fujiwara,T., 2006

Epilepsy Syndromes in Infancy
Pediatr Neurol 34:253-263, Korff,C.M. &Nordii,D.R.,Jr., 2006

Diffusion-Weighted MR Imaging Characteristics of an Acute Strokelike Form of Multiple Sclerosis
AJNR 27:1006-1008, Rosso,C.,et al, 2006

Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
JAMA 296:2832-2838, Munger,K.L.,et al, 2006

Dementia and White-Matter Demyelination in Young Patient With Neurosyphilis
Lancet:368:2258, Brinar,V.V. &Habek,M., 2006

CNS Involvement in Hereditary Neuropathy With Pressure Palsies (HNPP)
Neurol 67:2250-2252, Tackenberg,B.,et al, 2006

High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Arch Neurol 63:1388-1393, Gladstone,D.E.,et al, 2006

Neuromyelitis Optica IgG Status in Acute Partial Transverse Myelitis
Arch Neurol 63:1398-1400, Scott,T.F.,et al, 2006

Treatment With Interferon beta-1b Delays Conversion to Clinically Definite and McDonald MS in Patients With Clinically Isolated Syndromes
Neurol 67:1242-1249, Kappos,L.,et al, 2006

Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006

Baseline MRI Predicts Future Attacks and Disability in Clinically Isolated Syndromes
Neurol 67:968-972, Tintore,M.,et al, 2006

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis
AJNR 27:2161-2167, Bagnato,F.,et al, 2006

Pathologic Laughing and Intractable Hiccups Can Occur Early in Multiple Sclerosis
Neurol 67:1684-1686, de Seze,J.,et al, 2006

Obsessive-Compulsive Disorder
BMJ 333:424-429, Heyman,I.,et al, 2006

Does High-Field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis
AJNR 27:1794-1798, Wattjes,M.P.,et al, 2006

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006

Multiple Sclerosis with and without CSF Bands:Clinically Indistinguishable but Immunogenetically Distinct
Neurol 67:1062-1064, Imrell,K.,et al, 2006

The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Multiple Sclerosis - The Plaque and Its Pathogenesis
NEJM 354:942-955, Frohman,E.M.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

Community-Acquired Bacterial Meningitis in Adults
NEJM 354:44-53, van de Beek,D.,et al, 2006

IM Interferon B-1a Delays Definite Multiple Sclerosis 5 Years After a First Demyelinating Event
Neurol 66:678-684, CHAMPIONS Study Group, 2006

Gray and White Matter Brain Atrophy and Neuropsychological Impairment in Multiple Sclerosis
Neurol 66:685-692, Sanfilipo,M.P.,et al, 2006

Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006

Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006

Clinically Isolated Syndromes, A New Oligoclonal Band Test Accurately Predicts Conversion to MS
Neurol 66:576-578, Masjuan,J.,et al, 2006

Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006

Diagnosis and Treatment of Multiple Sclerosis
BMJ 332:525-527, Murray,T.J., 2006

Cerebral Sinovenous Thrombosis in the Neonate
Arch Neurol 63:405-409, Fitzgerald,K.C.,et al, 2006

Treatment of Low Back Pain by Acupressure and Physical Therapy: Randomised Controlled Trial
BMJ 332:696-698,680, Hsieh,L.L.-C.,et al, 2006

Magnetic Resonance Imaging as a Surrogate Outcome Measure of Disability in Multiple Sclerosis: Have We Been Overly Harsh in Our Assessment?
Ann Neurol 59:597-605, Goodin,D.S., 2006

Most Patients With Multiple Sclerosis or a Clinically Isolated Demyelinating Syndrome Should be Treated at the Time of Diagnosis
Arch Neurol 63:614-619, Frohman,E.M.,et al, 2006

Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis
Arch Neurol 63:611-619, Pittock,S.J.,et al, 2006

Increase in Multiple Sclerosis Relapse Rate Following in vitro Fertilization
Neurol 66:1280-1281, Laplaud,D.-A.,et al, 2006

Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy
Stroke 37:1217-1220, Somerfield,J.,et al, 2006

Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006

Showing articles 600 to 650 of 5493 << Previous Next >>